Dr. Sanchorawala speaks on ASCT in AL amyloidosis
Vaishali Sanchorawala The successful use of novel agents and data drawn from the ANDROMEDA trial (NCT03201965) is referenced as to why the utility of ASCT in AL amyloidosis may be questioned. However, Dr Sanchorawala does go on to explain how for a small patient population, ASCT is still a very useful tool. This interview was […]
Dr. Sanchorawala presents at the ASH meeting on Hematologic Malignancies: virtual platform
Dr. Vaishali Sanchorawala presents at the ASH Meeting on Hematologic Malignancies: virtual platform on “How I treat systemic AL amyloidosis”.
Farewell to Dr. Shayna Sarosiek
With a mixture of sadness and pride, I would like to inform you that Shayna Sarosiek, MD will be leaving Boston University School of Medicine and Boston Medical Center after 11 years of dedicated service to our patients and center. She has accepted an offer to join Dana Farber Cancer Institute, and will be leaving […]